The use of high-frequency chest wall oscillation in patients with respiratory failure
https://doi.org/10.21518/2079-701X-2015-16-26-29
Abstract
One of the main challenges in patients with respiratory failure (RF) is to ensure effective functioning of an important defense mechanism of the respiratory system - mucociliary clearance (MCC). MCC is characterized by the upward movement of mucus by ciliary motion. The target of the protective function of MCC is to remove dust particles and pathological microorganisms through the vibrational of the cilia.
About the Author
N. N. Mescheryakova
Research Institute of Pulmonology, Federal Medical and Biological Agency of Russia, Moscow
Russian Federation
Russian Federation
References
1. Reid LM. The pathology of obstructive and inflammatory airway diseases. Eur. J respir Dis, 1986. 69 (147): 26-37.
2. Warwick WJ. Mechanisms of mucous transport. Eur. J. Respir Dis, 1983. 127: 162-167.
3. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and fyture trends. Lancet, 2007. 370: 765-773.
4. Bourdin A., Burgel P., Chanez P. et al. Recent advances in COPD: pathophysiology, respiratory physiology and clinical aspects, including comorbidities. Eur Respir review, 2009. 18: 198-212.
5. Майкл А. Гриппи. Патофизиология легких. Москва. БИНОМ. 2008. 27-33, 102-103.
6. Aliverti A, Stevenson N, Dellaca RL et al. Regional chest wall volumes during exercise in chronic obstructive pulmonary disease. Thorax, 2004. 59: 210-216.
7. Diaz O, Villafranca C, Ghezzo H et al. Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest. Eur Respir J., 2000. 16: 269-275.
8. Kirilliff LH, Owens GR, Rogers RM, Mazzocco MC. Does chest physiotherapy work? Chest, 1985. 83(3): 436444.
9. Diette GB, Rand CS, Wise RA et al. Feasibility of using a sham control device in clinical trials of High freguency Chest wall Oscillation (HFCWO) in COPD. Am. J. Respir Crit. Care Med, 2004. 167: 613.
10. Kempainen RR, Milla C, Duniz J et al. Comparison of setting used for high-freguency chest-wall compression in cyctic fibrosis. Respir. Care, 2010. 55 (6): 782-783.
11. Allan JS, Garrity GM, Donahue DM. High-freguency chest-wall compression during the 48 hours following thoracic surgery. Respir. Care, 2009. 54 (3): 340-343.
12. Nicolini A, Cardini F, Landucci N, Lanata S, Ferrari-Bravo M, Barlascini C. Effectiveness of treatment with high-frequency chest wall ascillation in patients with bronchiectasis. BMC Pulmonary Medicine, 2013. 13:21. C.1471-2466.
13. Rainer Gloeck, Inda Heinzeimann, Sandra Baeuerle, Eva Damm, Anna-Lena Schwedhelm, Merve Diril, David Buhrow, Andreas Jerrentup, Klaus Kenn. Effects of whole body vibration in patients with chronic obstructive pulmonary disease- A randomized controlled trial. Respiratory MEDICINE, january 2012. 106, 1: 75-83.
14. Wanger J, Clausen JL, Coates A et al. Standardisation of the measurement of lung volumes. Eur Respire.J., 2005. 26: 511-522.
15. Likert R. A technigue for the measurement of attitude. Archives of Psychology, 1932. 140: 1-55.
Review
For citations:
Mescheryakova NN. The use of high-frequency chest wall oscillation in patients with respiratory failure. Meditsinskiy sovet = Medical Council. 2015;(16):26-29. (In Russ.) https://doi.org/10.21518/2079-701X-2015-16-26-29
Views:
370
Email this article 